Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy

Cancer immunotherapy, especially immune checkpoint therapy, has revolutionized therapeutic options by reactivating the host immune system. However, the efficacy varies, and only a small portion of patients develop sustained antitumor responses. Hence, illustrating novel strategies that improve the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xianyong, Li, Chen, Chen, Tong, Li, Wenhao, Wang, Xiaolong, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942356/
https://www.ncbi.nlm.nih.gov/pubmed/36810108
http://dx.doi.org/10.1186/s12943-023-01746-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942356/
https://www.ncbi.nlm.nih.gov/pubmed/36810108
http://dx.doi.org/10.1186/s12943-023-01746-6

Ejemplares similares